Highlights,Janney Montgomery Scott LLC reduced its stake in Tarsus Pharmaceuticals by 10.5%.,Institutional and hedge funds ...

Around the world, millions of Christians see the Bible as the divine word of God - but who actually put pen to paper?

Healthcare plan provider Molina Healthcare, Inc. MOH is set to report fourth-quarter 2024 results on Feb. 5, 2025, after the ...

The president offered a proclamation Saturday to begin duties on Canada, Mexico, and China. Musk says Tesla's robotaxis will hit Austin this summer. But after years of unfulfilled promises, investors ...

IRVINE, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) -- . (NASDAQ: TARS), today announced that management will participate in ...

The partnership brings Darktrace's advanced cybersecurity and self-learning AI technology to customers across Africa.

Tarsus Pharmaceuticals (NASDAQ:TARS – Get Free Report) had its price objective lifted by equities researchers at Barclays from $60.00 to $62.00 in a research note issued on Monday,Benzinga reports.

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) was up 9% during trading on Monday after Barclays raised their price target on the stock from $60.00 to $62.00. Barclays currently has an ...

Global health insurance company The Cigna Group CI is set to report fourth-quarter 2024 results on Jan. 30, 2025, before the ...